BeyondSpring

+$18.04 (+187.33%) As of 7:33 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BeyondSpring and other ETFs, options, and stocks.

About BYSI

BeyondSpring, Inc. engages in the the development and commercialization of immuno-oncology cancer therapies to improve clinical outcomes for patients who have high unmet medical needs. It operates through PRC and U.S. geographical segments.

CEO
Lan Huang
Employees
91
Headquarters
New York, New York
Founded
2013

BYSI Key Statistics

Market Cap
1.32B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
157.93K
High Today
$30.00
Low Today
$20.57
Open Price
$28.10
Volume
78.65M
52 Week High
$30.00
52 Week Low
$8.90

BYSI News

Benzinga4h

Why BeyondSpring's Stock Is Rallying Today

BeyondSpring Inc. (NASDAQ: BYSI) shares are trading higher after the company announced results from its DUBLIN-3 trial of plinabulin in combination with docetax
MarketWatch6h

BeyondSpring stock more than triples after lung cancer treatment meets endpoints in Phase 3 trial

Shares of BeyondSpring Inc. BYSI, +1.58% more than tripled -- up 242% -- on heavy volume in premarket trading Wednesday, after the New York-headquartered biopha
MarketWatch8h

BeyondSpring Reports Encouraging Results From Cancer-Treatment Trial Involving Plinabulin

By Robb M. Stewart BeyondSpring Inc. said it plans to seek approval from U.S. and Chinese regulators for plinabulin, its lead asset, in combination with doceta

BYSI Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Sep 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure